SG11202110836SA - Peptides and compounds that bind to elongation initiation factor 4e - Google Patents
Peptides and compounds that bind to elongation initiation factor 4eInfo
- Publication number
- SG11202110836SA SG11202110836SA SG11202110836SA SG11202110836SA SG11202110836SA SG 11202110836S A SG11202110836S A SG 11202110836SA SG 11202110836S A SG11202110836S A SG 11202110836SA SG 11202110836S A SG11202110836S A SG 11202110836SA SG 11202110836S A SG11202110836S A SG 11202110836SA
- Authority
- SG
- Singapore
- Prior art keywords
- peptides
- bind
- compounds
- initiation factor
- elongation initiation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201902892R | 2019-03-29 | ||
| PCT/SG2020/050192 WO2020204828A1 (en) | 2019-03-29 | 2020-03-30 | Peptides and compounds that bind to elongation initiation factor 4e |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202110836SA true SG11202110836SA (en) | 2021-10-28 |
Family
ID=72667485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202110836SA SG11202110836SA (en) | 2019-03-29 | 2020-03-30 | Peptides and compounds that bind to elongation initiation factor 4e |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220242906A1 (en) |
| EP (1) | EP3947416A4 (en) |
| CN (1) | CN113646325A (en) |
| SG (1) | SG11202110836SA (en) |
| WO (1) | WO2020204828A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023069332A1 (en) * | 2021-10-22 | 2023-04-27 | Merck Sharp & Dohme Llc | Cell permeable macrocyclic peptides useful for eif4e cap-binding site inhibition |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6020162A (en) * | 1997-06-13 | 2000-02-01 | The Rockefeller University | Crystal of a protein-ligand complex containing an N-terminal truncated eIF4E, and methods of use thereof |
| CN1339492A (en) * | 2000-08-23 | 2002-03-13 | 上海博德基因开发有限公司 | New polypeptide-human translation initiation factor subunit eIF4E binding protein 17.27 and polynucleotide for encoding such polypeptide |
| US20110319338A1 (en) * | 2008-12-18 | 2011-12-29 | The Board Of Regents Of The University Of Texas System | Peptides that bind eukaryotic translation initiation factor 4e |
| FR2942798B1 (en) * | 2009-03-05 | 2011-04-08 | Centre Nat Rech Scient | PEPTIDES USEFUL FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA |
| WO2010138084A1 (en) * | 2009-05-28 | 2010-12-02 | Agency For Science, Technology And Research | CRYSTAL STRUCTURE OF CAP-FREE HUMAN eIF4E |
| US9018348B2 (en) * | 2010-04-27 | 2015-04-28 | Agency For Science, Technology And Research | eIF4E binding peptides |
| EP2870174A1 (en) * | 2012-07-09 | 2015-05-13 | F. Hoffmann-La Roche AG | Cell penetrating peptides to target eif4e |
| EP2976354A4 (en) * | 2013-03-21 | 2016-10-26 | Agency Science Tech & Res | STAPLING eIF4E INTERACTING PEPTIDES |
| WO2018073394A1 (en) * | 2016-10-19 | 2018-04-26 | Cellectis | Cell death inducing chimeric antigen receptors |
-
2020
- 2020-03-30 SG SG11202110836SA patent/SG11202110836SA/en unknown
- 2020-03-30 EP EP20782868.2A patent/EP3947416A4/en active Pending
- 2020-03-30 WO PCT/SG2020/050192 patent/WO2020204828A1/en unknown
- 2020-03-30 CN CN202080025505.7A patent/CN113646325A/en active Pending
- 2020-03-30 US US17/436,118 patent/US20220242906A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN113646325A (en) | 2021-11-12 |
| EP3947416A4 (en) | 2023-05-31 |
| US20220242906A1 (en) | 2022-08-04 |
| WO2020204828A1 (en) | 2020-10-08 |
| EP3947416A1 (en) | 2022-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287565A (en) | Antibodies that bind cd39 and uses thereof | |
| IL276063A (en) | Therapeutic molecules that bind to lag3 and pd1 | |
| SG11202110504XA (en) | ANTIBODIES TO PYROGLUTAMATE AMYLOID-ß AND USES THEREOF | |
| IL288412A (en) | Peptides | |
| EP4041772A4 (en) | Antibodies binding 4-1bb and uses thereof | |
| SG11202110836SA (en) | Peptides and compounds that bind to elongation initiation factor 4e | |
| PL3531481T3 (en) | Composite electrode materials | |
| IL285144A (en) | Therapeutic peptides | |
| GB202202417D0 (en) | Compression assist instructions | |
| GB2580664B (en) | Double load instruction | |
| GB201903412D0 (en) | Composite material | |
| GB201904720D0 (en) | Peptide synthesis and modification | |
| GB201900443D0 (en) | Cell-penetrating peptides | |
| IL287386A (en) | Promoter sequence and related products and uses thereof | |
| EP4056235A4 (en) | Oil-in-water composition | |
| EP4062073A4 (en) | Nutless bolt | |
| EP4013440A4 (en) | Therapeutic peptides | |
| GB201902531D0 (en) | Composite | |
| CA195436S (en) | Tent | |
| IL290019A (en) | Melanocyte-regulating peptides | |
| GB201913344D0 (en) | Composite materials | |
| EP4074303A4 (en) | Composition comprising p53-activating peptide | |
| GB201906982D0 (en) | Peptides | |
| GB201902850D0 (en) | Antimicroial peptides | |
| GB201919346D0 (en) | Composite products |